Strategies and methods to study female-specific cardiovascular health and disease

A guide for clinical scientists

Pamela Ouyang, Nanette K. Wenger, Doris Taylor, Janet W. Rich-Edwards, Meir Steiner, Leslee J. Shaw, Sarah L. Berga, Virginia M. Miller, Noel Bairey Merz

Research output: Contribution to journalReview article

Abstract

Background: In 2001, the Institute of Medicine's (IOM) report, "Exploring the Biological Contributions to Human Health: Does Sex Matter?" advocated for better understanding of the differences in human diseases between the sexes, with translation of these differences into clinical practice. Sex differences are well documented in the prevalence of cardiovascular (CV) risk factors, the clinical manifestation and incidence of cardiovascular disease (CVD), and the impact of risk factors on outcomes. There are also physiologic and psychosocial factors unique to women that may affect CVD risk, such as issues related to reproduction. Methods: The Society for Women's Health Research (SWHR) CV Network compiled an inventory of sex-specific strategies and methods for the study of women and CV health and disease across the lifespan. References for methods and strategy details are provided to gather and evaluate this information. Some items comprise robust measures; others are in development. Results: To address female-specific CV health and disease in population, physiology, and clinical trial research, data should be collected on reproductive history, psychosocial variables, and other factors that disproportionately affect CVD in women. Variables related to reproductive health include the following: age of menarche, menstrual cycle regularity, hormone levels, oral contraceptive use, pregnancy history/complications, polycystic ovary syndrome (PCOS) components, menopause age, and use and type of menopausal hormone therapy. Other factors that differentially affect women's CV risk include diabetes mellitus, autoimmune inflammatory disease, and autonomic vasomotor control. Sex differences in aging as well as psychosocial variables such as depression and stress should also be considered. Women are frequently not included/enrolled in mixed-sex CVD studies; when they are included, information on these variables is generally not collected. These omissions limit the ability to determine the role of sex-specific contributors to CV health and disease. Lack of sex-specific knowledge contributes to the CVD health disparities that women face. Conclusions: The purpose of this review is to encourage investigators to consider ways to increase the usefulness of physiological and psychosocial data obtained from clinical populations, in an effort to improve the understanding of sex differences in clinical CVD research and health-care delivery for women and men.

Original languageEnglish (US)
Article number19
JournalBiology of Sex Differences
Volume7
Issue number1
DOIs
StatePublished - Mar 31 2016

Fingerprint

Cardiovascular Diseases
Disease
Health
health
Women's Health
Sex Characteristics
Reproductive History
Research
Hormones
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Menarche
Aptitude
Pregnancy Complications
Polycystic Ovary Syndrome
Reproductive Health
Menstrual Cycle
Oral Contraceptives
Menopause
menopause
psychosocial factors

Keywords

  • Cardiovascular disease
  • Sex-specific
  • Women

ASJC Scopus subject areas

  • Endocrinology
  • Gender Studies

Cite this

Strategies and methods to study female-specific cardiovascular health and disease : A guide for clinical scientists. / Ouyang, Pamela; Wenger, Nanette K.; Taylor, Doris; Rich-Edwards, Janet W.; Steiner, Meir; Shaw, Leslee J.; Berga, Sarah L.; Miller, Virginia M.; Merz, Noel Bairey.

In: Biology of Sex Differences, Vol. 7, No. 1, 19, 31.03.2016.

Research output: Contribution to journalReview article

Ouyang, P, Wenger, NK, Taylor, D, Rich-Edwards, JW, Steiner, M, Shaw, LJ, Berga, SL, Miller, VM & Merz, NB 2016, 'Strategies and methods to study female-specific cardiovascular health and disease: A guide for clinical scientists', Biology of Sex Differences, vol. 7, no. 1, 19. https://doi.org/10.1186/s13293-016-0073-y
Ouyang, Pamela ; Wenger, Nanette K. ; Taylor, Doris ; Rich-Edwards, Janet W. ; Steiner, Meir ; Shaw, Leslee J. ; Berga, Sarah L. ; Miller, Virginia M. ; Merz, Noel Bairey. / Strategies and methods to study female-specific cardiovascular health and disease : A guide for clinical scientists. In: Biology of Sex Differences. 2016 ; Vol. 7, No. 1.
@article{b167ab65c236499ea6b6c86f3b1d4874,
title = "Strategies and methods to study female-specific cardiovascular health and disease: A guide for clinical scientists",
abstract = "Background: In 2001, the Institute of Medicine's (IOM) report, {"}Exploring the Biological Contributions to Human Health: Does Sex Matter?{"} advocated for better understanding of the differences in human diseases between the sexes, with translation of these differences into clinical practice. Sex differences are well documented in the prevalence of cardiovascular (CV) risk factors, the clinical manifestation and incidence of cardiovascular disease (CVD), and the impact of risk factors on outcomes. There are also physiologic and psychosocial factors unique to women that may affect CVD risk, such as issues related to reproduction. Methods: The Society for Women's Health Research (SWHR) CV Network compiled an inventory of sex-specific strategies and methods for the study of women and CV health and disease across the lifespan. References for methods and strategy details are provided to gather and evaluate this information. Some items comprise robust measures; others are in development. Results: To address female-specific CV health and disease in population, physiology, and clinical trial research, data should be collected on reproductive history, psychosocial variables, and other factors that disproportionately affect CVD in women. Variables related to reproductive health include the following: age of menarche, menstrual cycle regularity, hormone levels, oral contraceptive use, pregnancy history/complications, polycystic ovary syndrome (PCOS) components, menopause age, and use and type of menopausal hormone therapy. Other factors that differentially affect women's CV risk include diabetes mellitus, autoimmune inflammatory disease, and autonomic vasomotor control. Sex differences in aging as well as psychosocial variables such as depression and stress should also be considered. Women are frequently not included/enrolled in mixed-sex CVD studies; when they are included, information on these variables is generally not collected. These omissions limit the ability to determine the role of sex-specific contributors to CV health and disease. Lack of sex-specific knowledge contributes to the CVD health disparities that women face. Conclusions: The purpose of this review is to encourage investigators to consider ways to increase the usefulness of physiological and psychosocial data obtained from clinical populations, in an effort to improve the understanding of sex differences in clinical CVD research and health-care delivery for women and men.",
keywords = "Cardiovascular disease, Sex-specific, Women",
author = "Pamela Ouyang and Wenger, {Nanette K.} and Doris Taylor and Rich-Edwards, {Janet W.} and Meir Steiner and Shaw, {Leslee J.} and Berga, {Sarah L.} and Miller, {Virginia M.} and Merz, {Noel Bairey}",
year = "2016",
month = "3",
day = "31",
doi = "10.1186/s13293-016-0073-y",
language = "English (US)",
volume = "7",
journal = "Biology of Sex Differences",
issn = "2042-6410",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Strategies and methods to study female-specific cardiovascular health and disease

T2 - A guide for clinical scientists

AU - Ouyang, Pamela

AU - Wenger, Nanette K.

AU - Taylor, Doris

AU - Rich-Edwards, Janet W.

AU - Steiner, Meir

AU - Shaw, Leslee J.

AU - Berga, Sarah L.

AU - Miller, Virginia M.

AU - Merz, Noel Bairey

PY - 2016/3/31

Y1 - 2016/3/31

N2 - Background: In 2001, the Institute of Medicine's (IOM) report, "Exploring the Biological Contributions to Human Health: Does Sex Matter?" advocated for better understanding of the differences in human diseases between the sexes, with translation of these differences into clinical practice. Sex differences are well documented in the prevalence of cardiovascular (CV) risk factors, the clinical manifestation and incidence of cardiovascular disease (CVD), and the impact of risk factors on outcomes. There are also physiologic and psychosocial factors unique to women that may affect CVD risk, such as issues related to reproduction. Methods: The Society for Women's Health Research (SWHR) CV Network compiled an inventory of sex-specific strategies and methods for the study of women and CV health and disease across the lifespan. References for methods and strategy details are provided to gather and evaluate this information. Some items comprise robust measures; others are in development. Results: To address female-specific CV health and disease in population, physiology, and clinical trial research, data should be collected on reproductive history, psychosocial variables, and other factors that disproportionately affect CVD in women. Variables related to reproductive health include the following: age of menarche, menstrual cycle regularity, hormone levels, oral contraceptive use, pregnancy history/complications, polycystic ovary syndrome (PCOS) components, menopause age, and use and type of menopausal hormone therapy. Other factors that differentially affect women's CV risk include diabetes mellitus, autoimmune inflammatory disease, and autonomic vasomotor control. Sex differences in aging as well as psychosocial variables such as depression and stress should also be considered. Women are frequently not included/enrolled in mixed-sex CVD studies; when they are included, information on these variables is generally not collected. These omissions limit the ability to determine the role of sex-specific contributors to CV health and disease. Lack of sex-specific knowledge contributes to the CVD health disparities that women face. Conclusions: The purpose of this review is to encourage investigators to consider ways to increase the usefulness of physiological and psychosocial data obtained from clinical populations, in an effort to improve the understanding of sex differences in clinical CVD research and health-care delivery for women and men.

AB - Background: In 2001, the Institute of Medicine's (IOM) report, "Exploring the Biological Contributions to Human Health: Does Sex Matter?" advocated for better understanding of the differences in human diseases between the sexes, with translation of these differences into clinical practice. Sex differences are well documented in the prevalence of cardiovascular (CV) risk factors, the clinical manifestation and incidence of cardiovascular disease (CVD), and the impact of risk factors on outcomes. There are also physiologic and psychosocial factors unique to women that may affect CVD risk, such as issues related to reproduction. Methods: The Society for Women's Health Research (SWHR) CV Network compiled an inventory of sex-specific strategies and methods for the study of women and CV health and disease across the lifespan. References for methods and strategy details are provided to gather and evaluate this information. Some items comprise robust measures; others are in development. Results: To address female-specific CV health and disease in population, physiology, and clinical trial research, data should be collected on reproductive history, psychosocial variables, and other factors that disproportionately affect CVD in women. Variables related to reproductive health include the following: age of menarche, menstrual cycle regularity, hormone levels, oral contraceptive use, pregnancy history/complications, polycystic ovary syndrome (PCOS) components, menopause age, and use and type of menopausal hormone therapy. Other factors that differentially affect women's CV risk include diabetes mellitus, autoimmune inflammatory disease, and autonomic vasomotor control. Sex differences in aging as well as psychosocial variables such as depression and stress should also be considered. Women are frequently not included/enrolled in mixed-sex CVD studies; when they are included, information on these variables is generally not collected. These omissions limit the ability to determine the role of sex-specific contributors to CV health and disease. Lack of sex-specific knowledge contributes to the CVD health disparities that women face. Conclusions: The purpose of this review is to encourage investigators to consider ways to increase the usefulness of physiological and psychosocial data obtained from clinical populations, in an effort to improve the understanding of sex differences in clinical CVD research and health-care delivery for women and men.

KW - Cardiovascular disease

KW - Sex-specific

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=84977608896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977608896&partnerID=8YFLogxK

U2 - 10.1186/s13293-016-0073-y

DO - 10.1186/s13293-016-0073-y

M3 - Review article

VL - 7

JO - Biology of Sex Differences

JF - Biology of Sex Differences

SN - 2042-6410

IS - 1

M1 - 19

ER -